retatrutide stomach issues UK | The Ultimate Guide | Latest Trial Retatrutide: The "Triple G" Peptide

Think drip, not spray

GLP1 and GIP agonists They include: Combination of GLP-1 and GIP A dual GLP-1 and GIP receptor agonist that enhances insulin secretion, slows gastric emptying, and promotes weight loss

What is the Retatrutide peptide

Transition protocols commonly use a 1 or 2 mg retatrutide bridge regardless of the prior tirzepatide dose

As their use has expanded, questions about cardiovascular safety have become increasingly important for both patients and clinicians

Monitoring your progress and making the right call The decision to continue, reduce, or stop GLP-1 therapy should be driven by data, not arbitrary timelines or gut feelings